Newsbenzinga
Biomarin, Ascendis Reach Mutually Beneficial Agreement Ending Global Patent Disputes
· Published
Article summary
BioMarin Pharmaceutical and Ascendis Pharma settled global patent disputes over Yuviwel, granting BioMarin significant royalty payments.
An excerpt from the original article.
Comments —
Loading comments…